Download Drug Therapy Protocols: Sodium bicarbonate 8.4%

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Clinical trial wikipedia , lookup

Theralizumab wikipedia , lookup

Transcript
Drug Therapy Protocols: Sodium bicarbonate 8.4%
Disclaimer and copyright
©2016 Queensland Government
All rights reserved. Without limiting the reservation of copyright, no person shall reproduce, store in a
retrieval system or transmit in any form, or by any means, part or the whole of the Queensland Ambulance
Service (‘QAS’) Clinical practice manual (‘CPM’) without the priorwritten permission of the Commissioner.
The QAS accepts no responsibility for any modification, redistribution or use of the CPM or any part
thereof. The CPM is expressly intended for use by QAS paramedics whenperforming duties and delivering
ambulance services for, and on behalf of, the QAS.
Under no circumstances will the QAS, its employees or agents, be liable for any loss, injury, claim, liability
or damages of any kind resulting from the unauthorised use of, or reliance upon the CPM or its contents.
While effort has been made to contact all copyright owners this has not always been possible. The QAS
would welcome notification from any copyright holder who has been omitted or incorrectly acknowledged.
All feedback and suggestions are welcome, please forward to:
[email protected]
Date
October, 2016
Purpose
Scope
Author
To ensure a consistent procedural approach to Sodium bicarbonate 8.4% administration.
Applies to all QAS clinical staff.
Clinical Quality & Patient Safety Unit, QAS
Review date
October, 2018
URL
https://ambulance.qld.gov.au/clinical.html
This work is licensed under the Creative Commons
This work is licensed under the Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0
Attribution-NonCommercial-NoDerivatives 4.0
International License. To view a copy of this license,
International License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Sodium bicarbonate 8.4%
October, 2016
Drug class
Contraindications
Alkalising agent
UNCONTROLLED WHEN PRINTED
Pharmacology
Sodium bicarbonate 8.4% is a hypertonic solution that acts as a buffer.
Excess hydrogen ions react with bicarbonate resulting in the formation of carbon dioxide and water. This action assists in restoring plasma pH to within normal ranges.[1–3]
Metabolism
• Nil
Precautions
UNCONTROLLED WHEN PRINTED
• Nil
Metabolised to CO2 and H2O.[1]
Indications
• Cardiac arrest:
Side effects
• Cerebral oedema
• Congestive heart failure
UNCONTROLLED WHEN PRINTED
- secondary to suspected hyperkalaemia (e.g. chronic renal failure)
- secondary to tricyclic antidepressant (TCA) overdose
Presentation
• Significant injury with potential for crush syndrome
• TCA overdose with QRS > 0.12 OR attributed seizure activity
• Vial, 100 mL sodium bicarbonate 8.4%
UNCONTROLLED WHEN PRINTED
• Suspected hyperkalaemia (with QRS widening AND/OR AV dissociation)
Onset (IV)
Duration (IV)
Half-life
Immediate
Variable
Variable
Figure 4.51
QUEENSLAND AMBULANCE SERVICE
891
Sodium bicarbonate 8.4%
October, 2016
Schedule
Adult dosages
• Unscheduled.
UNCONTROLLED WHEN PRINTED
• Cardiac arrest
Intraosseous injection (IO)
CCP
CCP
Intravenous injection (IV)
ECP
Routes of administration
- secondary to suspected hyperkalaemia (e.g. chronic renal failure)
- secondary to TCA overdose
• Significant injury with potential for crush syndrome
• Suspected hyperkalaemia (with QRS widening AND/OR UNCONTROLLED WHEN PRINTED
• Sodium bicarbonate 8.4% administration is not indicated in the newly born pre-hospital resuscitation.
CCP
• Care must be taken to avoid extravasation into tissues as necrosis may occur.
IV
ECP – QAS Clinical Consultation and Advice Line approval required in all situations.
100 mL. Single dose only.
CCP
Special notes
ECP
AV dissociation)
IO
100 mL. Single dose only.
UNCONTROLLED WHEN PRINTED
• The Phebra branded sodium bicarbonate vials are unable to be spiked with QAS supplied Alaris® giving sets. TCA overdose with QRS > 0.12 OR attributed seizure activity
• All cannulae and IV lines must be flushed thoroughly with sodium chloride 0.9% before and following each
CCP
using a 50 mL syringe and 19G drawing up needle.
ECP
All medication must be withdrawn and administered IV
ECP – QAS Clinical Consultation and Advice Line approval required in all situations.
100 mL
Repeated every 5 minutes.
Total maximum dose 300 mL.
UNCONTROLLED WHEN PRINTED
• All parenteral medications must be prepared in an aseptic
manner. The rubber stopper of all vials must be disinfected
with a 2% Chlorhexidine/70% Isopropyl Alcohol swab CCP
medication administration.
IO
100 mL
Repeated every 5 minutes.
Total maximum dose 300 mL.
and allowed to dry prior to piercing.
QUEENSLAND AMBULANCE SERVICE
892
Sodium bicarbonate 8.4%
Paediatric dosages
UNCONTROLLED WHEN PRINTED
• Cardiac arrest
- secondary to suspected hyperkalaemia (e.g. chronic renal failure)
- secondary to TCA overdose
• Significant injury with potential for crush syndrome
• Suspected hyperkalaemia (with QRS widening AND/OR UNCONTROLLED WHEN PRINTED
CCP
ECP
AV dissociation)
IV
ECP – QAS Clinical Consultation and Advice Line approval required in all situations.
1 mL/kg
Single dose only.
CCP
UNCONTROLLED WHEN PRINTED
IO
1 mL/kg
Single dose only.
UNCONTROLLED WHEN PRINTED
894 QUEENSLAND AMBULANCE SERVICE
893